Thursday, July 31, 2025 11:47:05 AM
Thats an unfortunate result of the con game here.
I mentioned previously that another stock im watching the board issued mgmt preferred shares. Oddly, seemingly counterintuitive, they did so just before a reverse split. That RS increased their conversion price and subsequently increased their cost basis, thus reducing the amount of shares of common as it should. Why would the board issue mgmt preferred before said RS knowing all that? Well it just so happens those preferred have a clause that rounds the conversion to the nearest whole share, so regardless of how many reverse splits occurs, they still get 1 common per preferred while the cost basis increases. Since these preferred didnt cost mgmt any money, it seems, they included an original price of $2 to establish a cost basis.
Now management of that company has incentive to see the stockprice drop and additional reverse splits executed. Why, because their potential paper loss increases with each consecutive RS while they still get 1 share per preferred because the conversion is always rounded up to the nearest whole share.
If I am understanding things correctly, when they go to finally sell those common, they'll potentially have a much larger cost basis (paper loss) to tax shelter any real profit from the sell of those shares. It'll be interesting to watch and confirm what i suspect.
I predicted the first RS, that companies board had already determined the ratio while management said it had no intent to RS. I predict there will be another one by Spring next year for this company. I wouldnt be surprised if the board issues another tranche of preferred before said RS.
I mentioned previously that another stock im watching the board issued mgmt preferred shares. Oddly, seemingly counterintuitive, they did so just before a reverse split. That RS increased their conversion price and subsequently increased their cost basis, thus reducing the amount of shares of common as it should. Why would the board issue mgmt preferred before said RS knowing all that? Well it just so happens those preferred have a clause that rounds the conversion to the nearest whole share, so regardless of how many reverse splits occurs, they still get 1 common per preferred while the cost basis increases. Since these preferred didnt cost mgmt any money, it seems, they included an original price of $2 to establish a cost basis.
Now management of that company has incentive to see the stockprice drop and additional reverse splits executed. Why, because their potential paper loss increases with each consecutive RS while they still get 1 share per preferred because the conversion is always rounded up to the nearest whole share.
If I am understanding things correctly, when they go to finally sell those common, they'll potentially have a much larger cost basis (paper loss) to tax shelter any real profit from the sell of those shares. It'll be interesting to watch and confirm what i suspect.
I predicted the first RS, that companies board had already determined the ratio while management said it had no intent to RS. I predict there will be another one by Spring next year for this company. I wouldnt be surprised if the board issues another tranche of preferred before said RS.
https://investorshub.advfn.com/Bostons-research-43724
Could it be that there is a strategy to distract people away from looking at basic data?
Is it an exercise to create forum verbiage to drown out any serious discussion of evidence?
Recent SINT News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/27/2026 07:00:23 PM
- SINTX Technologies to Present at the LD Micro Invitational XVI Conference • Newsfile • 05/17/2026 07:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 12:30:10 PM
- SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution • GlobeNewswire Inc. • 03/23/2026 01:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/20/2026 09:00:53 PM
- SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant • GlobeNewswire Inc. • 03/19/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 01:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:35:38 PM
- SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms • GlobeNewswire Inc. • 02/18/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:45:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:44:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:43:48 AM
- SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 • GlobeNewswire Inc. • 01/29/2026 02:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/12/2025 05:15:20 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/09/2025 10:01:07 PM
- Sidoti Events, LLC's Year-End Virtual Investor Conference • ACCESS Newswire • 12/09/2025 05:48:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 01:00:05 PM
- SINTX Technologies to Participate in Sidoti & Company Investor Conference • GlobeNewswire Inc. • 12/08/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 01:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:35:26 PM
- SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
